60 Degrees Pharmaceuticals, Inc. (SXTP): Total Liabilities

Annual figures by period end, from SEC filings.

$1.99M
As of 2025-12-31
$2.34M
As of 2026-09-30
-57.3%
3-year compound annual growth
$25.45M2022-12-31: $25.45M2023-12-31: $2.99M2024-12-31: $1.80M2025-12-31: $1.99M$1.99M
2022-12-31 Total Liabilities (USD) 2025-12-31
Period endedTotal LiabilitiesChange YoYSource filing
2025-12-31$1.99M+10.1%2026-03-30, Balance as of period end
2024-12-31$1.80M-39.6%2026-03-30, Balance as of period end
2023-12-31$2.99M-88.3%2025-03-27, Balance as of period end
2022-12-31$25.45Mn/a2024-04-01, Balance as of period end

Total Liabilities at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal LiabilitiesChange YoY
60 Degrees Pharmaceuticals, Inc. (SXTP)2025-12-31$1.99M+10.1%
Shattuck Labs, Inc. (STTK)2025-12-31$8.64M-24.4%
Dare Bioscience, Inc. (DARE)2025-12-31$29.63M+5.4%
China SXT Pharmaceuticals, Inc. (SXTC)2026-03-31$5.05M-18.9%
Rafael Holdings, Inc. (RFL)2026-07-31$11.09M-29.6%
Neuphoria Therapeutics Inc. (NEUP)2026-06-30$4.11M-57.1%
Rallybio Corp (RLYB)2025-12-31$4.30M-33.3%
Longeveron Inc. (LGVN)2025-12-31$4.59M+24.9%
Onconetix, Inc. (ONCO)2025-12-31$9.16M-50.7%

Compare SXTP, STTK, DARE, SXTC side by side · Screen every company in Pharmaceutical Preparations ↗